Barely Significant
← all excerpts

Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed/Refractory Multiple Myeloma: Real World Evidence from Italy.

Clinicoecon Outcomes Res · 2025 · PMC12285882 · PMID 40704066

Europe PMCDOI
1
hedged sentence
0.0580
closest p · 1.2× alpha
0.0580
boldest claim

The sentences

nearly significantP=0.058so close (0.05 < p ≤ 0.1)
IxaRd triplet also showed a trend towards a higher DOT (3.3 months higher than KRd), although nearly significant (P=0.058).

also in 3,349 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.